Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems

In 2010, World Health Organization (WHO) reclassified pancreatic neuroendocrine tumors (p-NETs) into 4 main groups: neuroendocrine tumor G1 (NET G1), neuroendocrine tumor G2 (NET G2), neuroendocrine carcinoma G3 (NEC G3), mixed adeno and neuroendocrine carcinoma (MANEC). Clinical value of these newl...

Full description

Bibliographic Details
Main Authors:	Yang, Min, Ke, Neng-wen, Zeng, Lin, Zhang, Yi, Tan, Chun-lu, Zhang, Hao, Mai, Gang, Tian, Bo-le, Liu, Xu-bao
Format:	Online
Language:	English
Published:	Wolters Kluwer Health 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674199/

id	pubmed-4674199
recordtype	oai_dc
spelling	pubmed-46741992015-12-14 Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems Yang, Min Ke, Neng-wen Zeng, Lin Zhang, Yi Tan, Chun-lu Zhang, Hao Mai, Gang Tian, Bo-le Liu, Xu-bao 4300 In 2010, World Health Organization (WHO) reclassified pancreatic neuroendocrine tumors (p-NETs) into 4 main groups: neuroendocrine tumor G1 (NET G1), neuroendocrine tumor G2 (NET G2), neuroendocrine carcinoma G3 (NEC G3), mixed adeno and neuroendocrine carcinoma (MANEC). Clinical value of these newly updated WHO grading criteria has not been rigorously validated. The authors aimed to evaluate the clinical consistency of the new 2010 grading classifications by WHO and the 2010 tumor-node metastasis staging systems by American Joint Committee on Cancer (AJCC) on survivals for patients with surgically resected p-NETs. Moreover, the authors would validate the prognostic value of both criteria for p-NETs. Wolters Kluwer Health 2015-12-07 /pmc/articles/PMC4674199/ /pubmed/26632896 http://dx.doi.org/10.1097/MD.0000000000002156 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Yang, Min Ke, Neng-wen Zeng, Lin Zhang, Yi Tan, Chun-lu Zhang, Hao Mai, Gang Tian, Bo-le Liu, Xu-bao
spellingShingle	Yang, Min Ke, Neng-wen Zeng, Lin Zhang, Yi Tan, Chun-lu Zhang, Hao Mai, Gang Tian, Bo-le Liu, Xu-bao Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems
author_facet	Yang, Min Ke, Neng-wen Zeng, Lin Zhang, Yi Tan, Chun-lu Zhang, Hao Mai, Gang Tian, Bo-le Liu, Xu-bao
author_sort	Yang, Min
title	Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems
title_short	Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems
title_full	Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems
title_fullStr	Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems
title_full_unstemmed	Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems
title_sort	survival analyses for patients with surgically resected pancreatic neuroendocrine tumors by world health organization 2010 grading classifications and american joint committee on cancer 2010 staging systems
description	In 2010, World Health Organization (WHO) reclassified pancreatic neuroendocrine tumors (p-NETs) into 4 main groups: neuroendocrine tumor G1 (NET G1), neuroendocrine tumor G2 (NET G2), neuroendocrine carcinoma G3 (NEC G3), mixed adeno and neuroendocrine carcinoma (MANEC). Clinical value of these newly updated WHO grading criteria has not been rigorously validated. The authors aimed to evaluate the clinical consistency of the new 2010 grading classifications by WHO and the 2010 tumor-node metastasis staging systems by American Joint Committee on Cancer (AJCC) on survivals for patients with surgically resected p-NETs. Moreover, the authors would validate the prognostic value of both criteria for p-NETs.
publisher	Wolters Kluwer Health
publishDate	2015
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674199/
_version_	1613511334030213120

Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems

Similar Items